Acquisition / mergerNotableFiled on BSE ·

Jaikisan Agrotech India Limited files draft prospectus for SME IPO on BSE

Bliss GVS Pharma

Arthneeti Research DeskPublished 1 min read

Key highlights

  • Proposes an initial public offering of 49,18,000 equity shares of face value ₹10 each on SME platform of BSE Limited in 2026
  • IPO price, number of shares reserved for market maker, and total issue size not disclosed; compliant with SEBI ICDR Regulations
  • Draft Prospectus publicly available for comments for 21 days from filing date; subscription through ASBA process only

Why it's rated notable: amount is ₹500 crore or more

Original filing

Post-Offer Advertisement

Read the filing on BSE (PDF) →

Companies guiding to strong growth

Ranked by management's own guidance on revenue and margins — not by us.

Rossell Techsys

Aerospace & Defense

Revenue growth 40%+Margin up 2%+

Sign up free to see all 6 →

See full rankings

Rank buckets describe management commentary on revenue and margin. Not investment advice, and not a forecast of returns.

More from Bliss GVS Pharma

Other acquisition / merger filings this fortnight

All acquisition / merger filings →

Summary written by Arthneeti from the company's filing with the stock exchange; check the original filing for full details. Arthneeti is a research and analytics platform, not a SEBI-registered investment adviser, and nothing here is a recommendation to buy or sell.